1. Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label therapy
   Christian K. Hirt et al, 2022, Cell Genomics CrossRef
2. Pristimerin overcomes adriamycin resistance in breast cancer cells through suppressing Akt signaling
   GUI'E XIE et al, 2016, Oncology Letters CrossRef
3. Trifluoperazine, an Antipsychotic Drug, Effectively Reduces Drug Resistance in Cisplatin-Resistant Urothelial Carcinoma Cells via Suppressing Bcl-xL: An In Vitro and In Vivo Study
   Kuan-Lin Kuo et al, 2019, International Journal of Molecular Sciences CrossRef
4. Identification of Emetine as a Therapeutic Agent for Pulmonary Arterial Hypertension
   Mohammad Abdul Hai Siddique et al, 2019, Arteriosclerosis, Thrombosis, and Vascular Biology CrossRef
5. Targeting histone deacetylase and NFκB signaling as a novel therapy for Mucoepidermoid Carcinomas
   Vivian P. Wagner et al, 2018, Scientific Reports CrossRef
6. In vitro screening of effectiveness and antiproliferative effects of potential ddit4 inhibitors for breast cancer cell lines
   E. M. Zhidkova et al, 2022, Siberian journal of oncology CrossRef
7. Genome-wide siRNA screens identify RBBP9 function as a potential target in Fanconi anaemia-deficient head-and-neck squamous cell carcinoma
   Govind Pai et al, 2023, Communications Biology CrossRef
8. Alkaloids as potential anticancer agent
   Mayuri A. Patil et al, 2023, Recent Frontiers of Phytochemicals CrossRef
9. Molecular mechanisms of action and chemosensitization of tumor cells in ovarian cancer by phytochemicals: A narrative review on pre‐clinical and clinical studies
   Josianne Rocha Barboza et al, 2023, Phytotherapy Research CrossRef
10. Overcoming adaptive resistance in mucoepidermoid carcinoma through inhibition of the IKK-β/IκBα/NFκB axis
    Vivian P. Wagner et al, 2016, Oncotarget CrossRef
11. Identification of microR-106b as a prognostic biomarker of p53-like bladder cancers by ActMiR
    Eunjee Lee et al, 2018, Oncogene CrossRef
12. Inhibition of the NRF2/KEAP1 Axis: A Promising Therapeutic Strategy to Alter Redox Balance of Cancer Cells
    Emiliano Panieri et al, 2021, Antioxidants & Redox Signaling CrossRef
13. Cisplatin in combination with emetine and patulin showed dose and sequence dependent synergism against ovarian cancer
    Md Nur Alam et al, 2020, Synergy CrossRef
14. Therapeutic targeting of the USP2-E2F4 axis inhibits autophagic machinery essential for zinc homeostasis in cancer progression
    Wenjing Xiao et al, 2022, Autophagy CrossRef
15. Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Endometrial Carcinoma to Immunotherapy and Chemotherapy
    Jinhui Liu et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
16. Overexpression of miR-216b sensitizes NSCLC cells to cisplatin-induced apoptosis by targeting c-Jun
    Gang Huang et al, 2017, Oncotarget CrossRef
17. Platinum-Based Combination Therapy: Molecular Rationale, Current Clinical Uses, and Future Perspectives
    Chunqiu Yu et al, 2020, Journal of Medicinal Chemistry CrossRef
18. Exploring the potential mechanism of emetine against coronavirus disease 2019 combined with lung adenocarcinoma: bioinformatics and molecular simulation analyses
    Kun Zhang et al, 2022, BMC Cancer CrossRef
19. Proadifen sensitizes resistant ovarian adenocarcinoma cells to cisplatin
    Rastislav Jendželovský et al, 2016, Toxicology Letters CrossRef
20. Emetine Synergizes with Cisplatin to Enhance Anti-Cancer Efficacy against Lung Cancer Cells
    Ti-Hui Wu et al, 2019, International Journal of Molecular Sciences CrossRef
21. Application of emetine in SARS-CoV-2 treatment: regulation of p38 MAPK signaling pathway for preventing emetine-induced cardiac complications
    Mehdi Valipour et al, 2022, Cell Cycle CrossRef
22. Aberrant Bcl-x splicing in cancer: from molecular mechanism to therapeutic modulation
    Zhihui Dou et al, 2021, Journal of Experimental & Clinical Cancer Research CrossRef
23. Reference Module-Based Analysis of Ovarian Cancer Transcriptome Identifies Important Modules and Potential Drugs
    Xuedan Lai et al, 2022, Biochemical Genetics CrossRef